KR101315595B1 - 살리노스포르아미드 및 그의 사용 방법 - Google Patents
살리노스포르아미드 및 그의 사용 방법 Download PDFInfo
- Publication number
- KR101315595B1 KR101315595B1 KR1020127016459A KR20127016459A KR101315595B1 KR 101315595 B1 KR101315595 B1 KR 101315595B1 KR 1020127016459 A KR1020127016459 A KR 1020127016459A KR 20127016459 A KR20127016459 A KR 20127016459A KR 101315595 B1 KR101315595 B1 KR 101315595B1
- Authority
- KR
- South Korea
- Prior art keywords
- neoplasm
- pharmaceutical composition
- cancer
- formula
- compound
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/600,854 | 2003-06-20 | ||
US10/600,854 US7179834B2 (en) | 2002-06-24 | 2003-06-20 | Salinosporamides and methods for use thereof |
US10/838,157 | 2004-04-30 | ||
US10/838,157 US7176232B2 (en) | 2002-06-24 | 2004-04-30 | Salinosporamides and methods for use thereof |
PCT/US2004/019453 WO2005003137A1 (en) | 2003-06-20 | 2004-06-18 | Salinosporamides and methods for use thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057024462A Division KR101183784B1 (ko) | 2003-06-20 | 2004-06-18 | 살리노스포르아미드 및 그의 사용 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120081637A KR20120081637A (ko) | 2012-07-19 |
KR101315595B1 true KR101315595B1 (ko) | 2013-10-08 |
Family
ID=46713688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020127016459A KR101315595B1 (ko) | 2003-06-20 | 2004-06-18 | 살리노스포르아미드 및 그의 사용 방법 |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR101315595B1 (pt) |
CY (1) | CY1116724T1 (pt) |
DK (1) | DK2441767T3 (pt) |
ES (1) | ES2546415T3 (pt) |
IL (1) | IL240236B (pt) |
MX (1) | MX361003B (pt) |
PT (1) | PT2441767E (pt) |
SI (1) | SI2441767T1 (pt) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002047610A2 (en) | 2000-11-16 | 2002-06-20 | The Regents Of The University Of California | Marine actinomycete taxon for drug and fermentation product dicovery |
-
2004
- 2004-06-18 KR KR1020127016459A patent/KR101315595B1/ko active IP Right Grant
- 2004-06-18 MX MX2013010748A patent/MX361003B/es unknown
- 2004-06-18 PT PT111637377T patent/PT2441767E/pt unknown
- 2004-06-18 SI SI200432255T patent/SI2441767T1/sl unknown
- 2004-06-18 DK DK11163737.7T patent/DK2441767T3/en active
- 2004-06-18 ES ES11163737.7T patent/ES2546415T3/es active Active
-
2015
- 2015-07-30 IL IL240236A patent/IL240236B/en active IP Right Grant
- 2015-08-25 CY CY20151100744T patent/CY1116724T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002047610A2 (en) | 2000-11-16 | 2002-06-20 | The Regents Of The University Of California | Marine actinomycete taxon for drug and fermentation product dicovery |
Also Published As
Publication number | Publication date |
---|---|
PT2441767E (pt) | 2015-10-09 |
CY1116724T1 (el) | 2017-03-15 |
KR20120081637A (ko) | 2012-07-19 |
IL240236A0 (en) | 2015-09-24 |
MX361003B (es) | 2018-11-23 |
ES2546415T3 (es) | 2015-09-23 |
SI2441767T1 (sl) | 2015-10-30 |
IL240236B (en) | 2021-02-28 |
DK2441767T3 (en) | 2015-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101183784B1 (ko) | 살리노스포르아미드 및 그의 사용 방법 | |
US7179834B2 (en) | Salinosporamides and methods for use thereof | |
US8217072B2 (en) | Salinosporamides and methods for use thereof | |
KR101315595B1 (ko) | 살리노스포르아미드 및 그의 사용 방법 | |
US7521414B2 (en) | Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140 | |
KR20050109958A (ko) | Gm-95 물질을 함유하는 항종양 효과 증강제, 항종양용조합 제제 및 항종양제 | |
US6277860B1 (en) | Furopyridine antibacterials | |
KR100225458B1 (ko) | 믹소코크스 속의 점액세균, 이로부터 생산되는 신규 항종양활성 화합물 및 그의 제조방법 | |
AU2007209992A1 (en) | Crystalline forms of a farnesyl dibenzodiazepinone | |
WO2024043829A1 (en) | Antimicrobial compounds, methods of production and uses thereof | |
EP0999212B1 (en) | Furopyridine antibacterials | |
EP0447494A1 (en) | Altromycin compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160912 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20171121 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180907 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190917 Year of fee payment: 7 |